Quick Answer
ECARX Holdings Inc. reported R&D Expense of $123.34 million for fiscal year 2025.
ECARX Holdings Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $123.34M | -29.5% |
| 2024 | $174.86M | -1.6% |
| 2023 | $177.68M | -86.7% |
| 2022 | $1.33B | +10.2% |
| 2021 | $1.21B | +71.3% |
| 2020 | $706.02M | — |
- ECARX Holdings Inc. showed a decrease of -29.5% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2025 period, ECARX Holdings Inc.’s r&d expense has declined by 82.5% (from $706.02 million to $123.34 million).
- The most recent figure is from ECARX Holdings Inc.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: